OXIA THERAPEUTICS
Live / Applied — Suspended — suspension letter mailed (as of 14 Oct 2026)
What this means for you
Not registered yet, but its 12 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99650792
- Mark type
- Word mark
- Filed
- 12 Feb 2026
- Attorney of record
- Delfina S. Homen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer
- Class 042 — Scientific and technological services: Pharmaceutical, scientific, and medical research and development services; scientific and medical research, namely, compiling and sharing of patient data and outcomes for research purposes; providing medical and scientific research information
Owner
- Oxia, Inc., Gainesville, GA, US
Prosecution history
- 14 Oct 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 14 Oct 2026 — LETTER OF SUSPENSION E-MAILED
- 14 Oct 2026 — SUSPENSION LETTER WRITTEN
- 11 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Jun 2026 — NON-FINAL ACTION E-MAILED
- 12 Jun 2026 — NON-FINAL ACTION WRITTEN
- 12 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Jun 2026 — NON-FINAL ACTION E-MAILED
- 12 Jun 2026 — NON-FINAL ACTION WRITTEN
- 12 Jun 2026 — ASSIGNED TO EXAMINER
- 11 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Feb 2026 — APPLICATION FILING RECEIPT MAILED